Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Isra Medical Journal. 2013; 5 (1): 54-57
em Inglês | IMEMR | ID: emr-195657

RESUMO

Chondrocalcinosis and Menicial injuries are both common findings on knee X ray and MRI [magnetic resonance Imaging] respectively. When both findings coexist in the setting of a painful knee effusion, they can lead to a diagnostic dilemma which is not always easy to sort out. This case report describes such a situation

2.
Isra Medical Journal. 2012; 4 (2): 76-80
em Inglês | IMEMR | ID: emr-194435

RESUMO

OBJECTIVE: To assess the role of Disodium pamidronate [ 3-amino-1-hydroxypropylidine-1,1-bisphosphonate] in the management of Rheumatoid Arthritis


STUDY DESIGN: A prospective, open, randomized, observational, dose response comparasion [30 mg vs 15 mg of Disodium Pamidronate] study done in the medical department of Cantonment General Hospital Rawalpindi over a three month period


PATIENTS AND METHODS: 16 patients of both genders with rheumatoid arthritis were divided into two groups of 8 each. [Designated A and B.].All patients had established Rhuematoid Arthritis according to 1987 American Rheumatology association revised criteria for the diagnosis of Rheumatoid Arthritis. Each group was randomly allocated to receive a single infusion of Disodium Pamidronate of either 15 [group A] or 30 mg [group B] . A number of parameters of disease activity were recorded [Grip strength [dominant hand; mean of three readings],Ritchie articular index, and early morning stiffness among others]. All patients were admitted and directly observed initially


RESULTS: Group A: Was given 15 mg Pamidronate infusion.Two [2] patients [25 %] showed improvement in clinical parameters and biochemical parameters. 6 patients showed biochemical improvement alone


Group B: Was given 30mg Pamidronate infusion. Five [5] patients [70%] showed rapid clinical and biochemical improvement which was relatively sustained for 1-3 months. All the 8 patients showed biochemical improvement. A transient flu like illness observed in one patient only however he was a responder


CONCLUSIONS: 30mg of single Disodium Pamidronate infusion in an efficacious and rapidly acting management strategy in the therapy of active rheumatoid arthritis. The response is dose related

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA